ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

DCE Advisors OK RFAs In Occupational Cancer, H. Pylori

April 1, 1994

Coalition Opens Web Site To Promote Cancer Trials.

June 15, 2001

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995